Page last updated: 2024-10-22

amfenac and Malignant Melanoma

amfenac has been researched along with Malignant Melanoma in 1 studies

amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the proliferation rates of five human uveal melanoma (UM) cell lines after treatment with amfenac, a cyclooxygenase (COX)-2 inhibitor, and subsequent radiation exposure."7.74Amfenac increases the radiosensitivity of uveal melanoma cell lines. ( Burnier, MN; Di Cesare, S; Fernandes, BF; Logan, P; Maloney, S; Marshall, JC, 2008)
"To evaluate the proliferation rates of five human uveal melanoma (UM) cell lines after treatment with amfenac, a cyclooxygenase (COX)-2 inhibitor, and subsequent radiation exposure."3.74Amfenac increases the radiosensitivity of uveal melanoma cell lines. ( Burnier, MN; Di Cesare, S; Fernandes, BF; Logan, P; Maloney, S; Marshall, JC, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernandes, BF1
Marshall, JC1
Di Cesare, S1
Logan, P1
Maloney, S1
Burnier, MN1

Other Studies

1 other study available for amfenac and Malignant Melanoma

ArticleYear
Amfenac increases the radiosensitivity of uveal melanoma cell lines.
    Eye (London, England), 2008, Volume: 22, Issue:5

    Topics: Cell Proliferation; Cyclooxygenase 2 Inhibitors; Humans; Melanoma; Phenylacetates; Radiation-Sensiti

2008